BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $517,236 | +267.5% | 73,056 | +265.5% | 0.00% | – |
| Q2 2023 | $140,730 | -38.4% | 19,990 | -27.0% | 0.00% | – |
| Q1 2023 | $228,516 | -92.4% | 27,400 | -89.6% | 0.00% | -100.0% |
| Q4 2022 | $3,014,705 | +66.8% | 262,605 | +83.1% | 0.01% | +60.0% |
| Q3 2022 | $1,807,000 | +678.9% | 143,389 | +554.1% | 0.01% | – |
| Q2 2022 | $232,000 | -65.9% | 21,920 | -47.7% | 0.00% | -100.0% |
| Q1 2022 | $681,000 | -83.1% | 41,932 | -85.5% | 0.00% | -84.6% |
| Q4 2021 | $4,019,000 | -57.9% | 290,122 | -56.4% | 0.01% | -60.6% |
| Q3 2021 | $9,553,000 | +4.2% | 664,803 | +14.6% | 0.03% | -8.3% |
| Q2 2021 | $9,171,000 | +4049.8% | 580,097 | +1861.6% | 0.04% | +3500.0% |
| Q4 2020 | $221,000 | +163.1% | 29,572 | -29.7% | 0.00% | 0.0% |
| Q1 2020 | $84,000 | -46.2% | 42,086 | -6.7% | 0.00% | 0.0% |
| Q4 2019 | $156,000 | +1633.3% | 45,086 | +3521.4% | 0.00% | – |
| Q3 2018 | $9,000 | -97.2% | 1,245 | -96.7% | 0.00% | -100.0% |
| Q1 2017 | $317,000 | +1409.5% | 37,700 | +1785.0% | 0.00% | – |
| Q4 2015 | $21,000 | -48.8% | 2,000 | -44.4% | 0.00% | – |
| Q3 2015 | $41,000 | +485.7% | 3,600 | +620.0% | 0.00% | – |
| Q2 2015 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |